Literature DB >> 7791840

Tuberculosis in New York City--turning the tide.

T R Frieden1, P I Fujiwara, R M Washko, M A Hamburg.   

Abstract

BACKGROUND: From 1978 through 1992, the number of patients with tuberculosis in New York City nearly tripled, and the proportion of such patients who had drug-resistant isolates of Mycobacterium tuberculosis more than doubled.
METHODS: We reviewed, confirmed, and analyzed data obtained during the surveillance of patients with tuberculosis.
RESULTS: From 1992 through 1994, there was a 21 percent decrease in reported cases of tuberculosis in New York City. An evaluation of the surveillance system revealed very few unreported cases. The number of cases decreased by more than 20 percent among blacks and Hispanics, persons with documented human immunodeficiency virus infection, homeless persons, and patients with multidrug-resistant tuberculosis; in all these groups, tuberculosis is likely to result from recent transmission. In contrast, the number of cases of tuberculosis increased among elderly and foreign-born persons, in whom the disease is likely to result from the reactivation of an infection acquired many years earlier. Enrollment in a program of directly observed therapy, in which health workers watch patients take their medications, increased from fewer than 100 patients to nearly 1300, with more than 32,000 patient-months of observation from 1992 through 1994.
CONCLUSIONS: Epidemiologic patterns strongly suggest that the decrease in cases resulted from an interruption in the ongoing spread of M. tuberculosis infection, primarily because of better rates of completion of treatment and expanded use of directly observed therapy. Another contributing factor may have been efforts to reduce the spread of tuberculosis in institutional settings, such as hospitals, shelters, and jails. Expansion of measures to prevent and control tuberculosis and support of international control efforts are needed to ensure continued progress.

Entities:  

Mesh:

Year:  1995        PMID: 7791840     DOI: 10.1056/NEJM199507273330406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  125 in total

Review 1.  Tuberculosis: 11. Nosocomial disease.

Authors:  K Schwartzman; D Menzies
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

2.  Criteria for the control of drug-resistant tuberculosis.

Authors:  C Dye; B G Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area.

Authors:  M Desvarieux; P R Hyppolite; W D Johnson; J W Pape
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

4.  Does directly observed therapy work?

Authors:  W J Burman; W el-Sadr
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

Review 5.  Latent tuberculosis infection: old problem, new priorities.

Authors:  Kevin Schwartzman
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

6.  Public health, civil liberties, and tuberculosis.

Authors:  R Coker
Journal:  BMJ       Date:  1999-05-29

7.  Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing?

Authors:  Dick Menzies
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

8.  Dash for DOT.

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1995-09

9.  The re-emergence of tuberculosis and its economic implications.

Authors:  H Sawert
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

10.  Lessons from New York's tuberculosis epidemic. Tuberculosis is a political as much as a medical problem-and so are the solutions.

Authors:  R Coker
Journal:  BMJ       Date:  1998-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.